publication venue for
- Response trajectories during escitalopram treatment of patients with major depressive disorder. 327:115361-115361. 2023
- Periodicity and severity of changes in depression and anxiety during the COVID-19 pandemic: Ten-wave longitudinal findings from an observational cohort study of community adults. 326:115267-115267. 2023
- The course of insomnia symptoms during the acute treatment of major depressive disorder: A CAN-BIND-1 report. 325:115222-115222. 2023
- Real world effectiveness of repeated ketamine infusions for treatment-resistant depression with comorbid borderline personality disorder. 323:115133-115133. 2023
- Subgroups of borderline personality disorder: A latent class analysis. 323:115131-115131. 2023
- Development and psychometric evaluation of a teacher version of the Ontario child health study emotional behavioural scales (OCHS-EBS-T) for measuring selected DSM-5 disorders in elementary school-aged children. 312:114574-114574. 2022
- Pain severity and pain interference during major depressive episodes treated with escitalopram and aripiprazole adjunctive therapy: a CAN-BIND-1 report. 312:114557-114557. 2022
- Pharmacotherapy of impulse control disorders: A systematic review. 311:114499-114499. 2022
- The impact of substance use disorder comorbidity on cognition of individuals with bipolar disorder: A systematic review. 311:114525-114525. 2022
- Exploring screening for borderline personality disorder in pediatric inpatients with psychiatric Illness. 309:114397-114397. 2022
- Early illness progression in mood disorders: A population-based longitudinal study. 306:114225-114225. 2021
- Real-world effectiveness of repeated ketamine infusions for treatment resistant depression during the COVID-19 pandemic. 303:114086-114086. 2021
- Risk factors for new-onset bipolar disorder in a community cohort: A five-year follow up study. 303:114109-114109. 2021
- Cognitive complaints in individuals recently diagnosed with bipolar disorder: A cross-sectional study. 300:113894-113894. 2021
- Sleep alterations in individuals recently diagnosed with bipolar disorder across different mood stages. 299:113824-113824. 2021
- Diffusion Tensor Imaging Reveals White Matter Differences in Military Personnel Exposed to Trauma with and without Post-traumatic Stress Disorder. 298:113797-113797. 2021
- Lithium-induced neuroprotective activity in neuronal and microglial cells: A purinergic perspective. 295:113562-113562. 2021
- Clarifying the role of sleep in depression: A narrative review. 291:113239-113239. 2020
- Emotional reactivity and explicit emotional memory biases in major depressive disorder during euthymia. 285:112847-112847. 2020
- Social media detox: Relapse predictors. 284:112488-112488. 2020
- A comparison of cluster and factor analytic techniques for identifying symptom-based dimensions of obsessive-compulsive disorder. 278:86-96. 2019
- Explicit emotional memory biases in mood disorders: A systematic review. 278:162-172. 2019
- Spontaneous spatial navigation circuitry in schizophrenia spectrum disorders. 278:125-128. 2019
- Clinical outcomes and childhood trauma in bipolar disorder: A community sample of young adults. 275:228-232. 2019
- Metabolic syndrome, depression and anhedonia among young adults. 271:306-310. 2019
- Prevalence of hoarding behaviours and excessive acquisition in users of online classified advertisements. 270:194-197. 2018
- Short abstinence from online social networking sites reduces perceived stress, especially in excessive users. 270:947-953. 2018
- Genetic analysis of impulsive personality traits: Examination of a priori candidates and genome-wide variation. 259:398-404. 2018
- Psychiatric comorbidity pattern in treatment-seeking veterans. 258:488-493. 2017
- Functional impairment and cognitive performance in mood disorders: A community sample of young adults. 251:85-89. 2017
- Subtle persistent working memory and selective attention deficits in women with premenstrual syndrome. 249:354-362. 2017
- Peripheral adenosine levels in euthymic patients with bipolar disorder. 246:421-426. 2016
- The predictive value of early treatment response in antipsychotic-naive patients with first-episode psychosis: Haloperidol versus olanzapine. 241:72-77. 2016
- Personality and coping in first episode psychosis linked to mental health care use. 238:218-224. 2016
- Altered emotional experiences attributed to antipsychotic medications – A potential link with estimated dopamine D2 receptor occupancy. 236:9-14. 2016
- Internet screening for anxiety disorders: Treatment-seeking outcomes in a three-month follow-up study. 230:689-694. 2015
- Emotional memory in pregnant women at risk for postpartum depression. 229:777-783. 2015
- Effects of a single bout of maximal aerobic exercise on BDNF in bipolar disorder: A gender-based response. 229:57-62. 2015
- Identifying latent profiles of posttraumatic stress and major depression symptoms in Canadian veterans: Exploring differences across profiles in health related functioning. 228:1-7. 2015
- Increased activity of frontal and limbic regions to emotional stimuli in children at-risk for anxiety disorders. 233:9-17. 2015
- Treatment delay is associated with more episodes and more severe illness staging progression in patients with bipolar disorder. 227:372-373. 2015
- The relationship between insight and autobiographical memory for emotional events in schizophrenia. 226:392-395. 2015
- Clarifying the neural basis for incentive salience of tobacco cues in smokers. 223:218-225. 2014
- Sleep disturbances and suicidal ideation in a sample of treatment-seeking Canadian Forces members and veterans. 218:118-123. 2014
- Somatic symptoms and health-related quality of life among treatment-seeking Canadian Forces personnel with PTSD. 218:148-152. 2014
- Proton magnetic resonance spectroscopy of prefrontal white matter in psychotropic naïve children and adolescents with obsessive–compulsive disorder. 222:67-74. 2014
- Changes in cortical thickness across the lifespan in major depressive disorder. 214:204-211. 2013
- Theory of mind deficits in patients with mild symptoms of major depressive disorder. 210:672-674. 2013
- Neural correlates of cognitive remediation in patients with mood disorders. 214:142-152. 2013
- Using a hybrid model to investigate the comorbidity and symptom overlap between social phobia and the other anxiety disorders and unipolar mood disorders. 210:188-192. 2013
- The Canadian Objective Assessment of Life Skills (COALS): A new measure of functional competence in schizophrenia. 206:302-306. 2013
- Personality correlates of pathological gambling derived from Big Three and Big Five personalitymodels. 206:50-55. 2013
- Impaired episodic memory for events encoded during mania in patients with bipolar disorder. 205:213-219. 2013
- Patients with bipolar disorder show impaired performance on complex tests of social cognition. 200:258-264. 2012
- Resting electrocortical activity in adults with dysfunctional anger: a pilot study. 203:229-236. 2012
- AGTR1 gene variation: Association with depression and frontotemporal morphology. 202:104-109. 2012
- The neuroeconomics of nicotine dependence: A preliminary functional magnetic resonance imaging study of delay discounting of monetary and cigarette rewards in smokers. 202:20-29. 2012
- Executive function and suicidal risk in women with Borderline Personality Disorder. 196:101-108. 2012
- Maternal history of depression is associated with enhanced theory of mind in depressed and nondepressed adult women. 189:91-96. 2011
- Altered empathic responding in major depressive disorder: Relation to symptom severity, illness burden, and psychosocial outcome. 188:231-236. 2011
- Episodic simulation of future events is impaired in patients with major depressive disorder. 187:465-467. 2011
- Gender differences in α-[11C]MTrp brain trapping, an index of serotonin synthesis, in medication-free individuals with major depressive disorder: A positron emission tomography study. 183:157-166. 2010
- Altered self-report of empathic responding in patients with bipolar disorder. 178:354-358. 2010
- Impaired theory of mind performance in patients with recurrent bipolar disorder: Moderating effect of cognitive load. 177:261-262. 2010
- Increased subgenual prefrontal cortex size in remitted patients with major depressive disorder. 173:71-76. 2009
- Increased choline-containing compounds in the orbitofrontal cortex and hippocampus in euthymic patients with bipolar disorder: A proton magnetic resonance spectroscopy study. 172:205-209. 2009
- Factor structure of the Multnomah Community Ability Scale – longitudinal analysis. 167:178-189. 2009
- Predictors of medication competence in schizophrenia patients. 157:47-52. 2008
- DNA damage in bipolar disorder. 153:27-32. 2007
- Manic symptoms and quality of life in bipolar disorder. 153:33-38. 2007
- MRI study of corpus callosum in children and adolescents with bipolar disorder. 146:83-85. 2006
- 1H Magnetic resonance spectroscopy study of dorsolateral prefrontal cortex in unipolar mood disorder patients. 138:131-139. 2005
- Subgenual prefrontal cortex of child and adolescent bipolar patients: a morphometric magnetic resonance imaging study. 138:43-49. 2005
- Anatomical MRI study of hippocampus and amygdala in patients with current and remitted major depression. 132:141-147. 2004
- A PET provocation study of generalized social phobia. 132:13-18. 2004
- Anatomical MRI study of basal ganglia in major depressive disorder. 124:129-140. 2003
- Schizophrenia and memory impairment: evidence for a neurocognitive subtype. 113:93-105. 2002
- MRI study of thalamic volumes in bipolar and unipolar patients and healthy individuals. 108:161-168. 2001
- Increased left posterior parietal–temporal cortex activation after d-fenfluramine in women with panic disorder. 98:133-143. 2000
- Serotonergic dysfunction in women with pure premenstrual dysphoric disorder: is the fenfluramine challenge test still relevant?. 87:107-115. 1999
- Functional magnetic resonance imaging in schizophrenia: initial methodology and evaluation of the motor cortex. 74:13-23. 1997
- Nocturnal melatonin and 24-hour 6-sulphatoxymelatonin levels in various phases of bipolar affective disorder. 63:219-222. 1996
- A reconsideration of the relationship between cerebral structural abnormalities and family history of schizophrenia. 53:41-55. 1994
- Effect of chronic antidepressant treatment with adinazolam and desipramine on melatonin output. 43:177-185. 1992
- Urinary catecholamines and cortisol in parasuicide. 43:31-42. 1992
- Apomorphine effects on brain metabolism in neuroleptic-naive schizophrenic patients. 40:135-153. 1991
- Retinal pigment epithelium response and the use of the EOG and arden ratio in depression. 36:175-185. 1991
- Sulphatoxy melatonin: An index of depression in anorexia nervosa and bulimia nervosa. 32:221-227. 1990
- Dose-response profiles of plasma growth hormone and vasopressin after clonidine challenge in man. 31:311-320. 1990
- The effect of lithium on pupillary response to pulses of light in sheep. 30:305-311. 1989
- Increased frontal and reduced parietal glucose metabolism in acute untreated schizophrenia. 28:119-133. 1989
- Seasonal variations in prolactin levels in Schizophrenia. 25:157-162. 1988
- Longitudinal growth hormone studies in schizophrenia. 24:123-136. 1988
- Sensitization and tolerance to apomorphine in men: Yawning, growth hormone, nausea, and hyperthermia. 23:245-255. 1988
- Effects of lithium administration on plasma catecholamines. 19:87-92. 1986
- Hormonal responses to zimelidine and desipramine in depressed patients. 13:231-242. 1984
- Erythrocyte lithium efflux in bipolar patients and control subjects: The question of reproducibility. 13:175-185. 1984
- Neuroendocrine responses to apomorphine in depressed patients and healthy control subjects. 13:1-12. 1984
- Neuroendocrine dysfunction in genetic subtypes of primary unipolar depression. 2:251-258. 1980
- Risk factors for new-onset bipolar disorder in a community cohort: A five-year follow up study 2021